These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32385370)

  • 1. Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer.
    Nair-Shalliker V; Bang A; Egger S; Clements M; Gardiner RA; Kricker A; Seibel MJ; Chambers SK; Kimlin MG; Armstrong BK; Smith DP
    Sci Rep; 2020 May; 10(1):7736. PubMed ID: 32385370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
    Fang F; Kasperzyk JL; Shui I; Hendrickson W; Hollis BW; Fall K; Ma J; Gaziano JM; Stampfer MJ; Mucci LA; Giovannucci E
    PLoS One; 2011 Apr; 6(4):e18625. PubMed ID: 21494639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men.
    Meyer HE; Støer NC; Samuelsen SO; Blomhoff R; Robsahm TE; Brustad M; Giovannucci EL; Bjørge T
    PLoS One; 2016; 11(3):e0151441. PubMed ID: 26986958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
    Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
    Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association among plasma 1,25(OH)
    Ramakrishnan S; Steck SE; Arab L; Zhang H; Bensen JT; Fontham ETH; Johnson CS; Mohler JL; Smith GJ; Su LJ; Woloszynska A
    Prostate; 2019 Jul; 79(10):1117-1124. PubMed ID: 31077420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.
    Dobnig H; Pilz S; Scharnagl H; Renner W; Seelhorst U; Wellnitz B; Kinkeldei J; Boehm BO; Weihrauch G; Maerz W
    Arch Intern Med; 2008 Jun; 168(12):1340-9. PubMed ID: 18574092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men.
    Lee DM; Vanderschueren D; Boonen S; O'Neill TW; Pendleton N; Pye SR; Ravindrarajah R; Gielen E; Claessens F; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Lean ME; Punab M; Wu FC;
    Age Ageing; 2014 Jul; 43(4):528-35. PubMed ID: 24375224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.
    Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma 25-Hydroxyvitamin D Concentrations Are Inversely Associated with All-Cause Mortality among a Prospective Cohort of Chinese Adults Aged ≥80 Years.
    Mao C; Li FR; Yin ZX; Lv YB; Luo JS; Yuan JQ; Mhungu F; Wang JN; Shi WY; Zhou JH; Chen GC; Gao X; Kraus VB; Wu XB; Shi XM
    J Nutr; 2019 Jun; 149(6):1056-1064. PubMed ID: 30949685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis.
    Holt SK; Kolb S; Fu R; Horst R; Feng Z; Stanford JL
    Cancer Epidemiol; 2013 Oct; 37(5):666-70. PubMed ID: 23972671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.
    Schmutz EA; Zimmermann MB; Rohrmann S
    Eur J Nutr; 2016 Feb; 55(1):393-402. PubMed ID: 25701092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.
    Bertone-Johnson ER; Chen WY; Holick MF; Hollis BW; Colditz GA; Willett WC; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1991-7. PubMed ID: 16103450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.
    Travis RC; Perez-Cornago A; Appleby PN; Albanes D; Joshu CE; Lutsey PL; Mondul AM; Platz EA; Weinstein SJ; Layne TM; Helzlsouer KJ; Visvanathan K; Palli D; Peeters PH; Bueno-de-Mesquita B; Trichopoulou A; Gunter MJ; Tsilidis KK; Sánchez MJ; Olsen A; Brenner H; Schöttker B; Perna L; Holleczek B; Knekt P; Rissanen H; Yeap BB; Flicker L; Almeida OP; Wong YYE; Chan JM; Giovannucci EL; Stampfer MJ; Ursin G; Gislefoss RE; Bjørge T; Meyer HE; Blomhoff R; Tsugane S; Sawada N; English DR; Eyles DW; Heath AK; Williamson EJ; Manjer J; Malm J; Almquist M; Marchand LL; Haiman CA; Wilkens LR; Schenk JM; Tangen CM; Black A; Cook MB; Huang WY; Ziegler RG; Martin RM; Hamdy FC; Donovan JL; Neal DE; Touvier M; Hercberg S; Galan P; Deschasaux M; Key TJ; Allen NE
    Cancer Res; 2019 Jan; 79(1):274-285. PubMed ID: 30425058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP.
    Steck SE; Arab L; Zhang H; Bensen JT; Fontham ET; Johnson CS; Mohler JL; Smith GJ; Su JL; Trump DL; Woloszynska-Read A
    PLoS One; 2015; 10(4):e0125151. PubMed ID: 25919866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D, PTH, and calcium in relation to survival following prostate cancer.
    Brändstedt J; Almquist M; Manjer J; Malm J
    Cancer Causes Control; 2016 May; 27(5):669-77. PubMed ID: 27023469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating 25-hydroxyvitamin D concentration and cause-specific mortality in the Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Kvaskoff D; Eyles DW; Giles GG; English DR; Williamson EJ
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105612. PubMed ID: 32007563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.
    Jacobs ET; Giuliano AR; Martínez ME; Hollis BW; Reid ME; Marshall JR
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):533-7. PubMed ID: 15225833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Freedman DM; Chang SC; Falk RT; Purdue MP; Huang WY; McCarty CA; Hollis BW; Graubard BI; Berg CD; Ziegler RG
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):889-94. PubMed ID: 18381472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.